Thursday, June 27, 2019 at 11:00am to 12:00pm
Conference Room 1122 – 1st Floor, Healthcare Consultation Center 2, 1122 1520 San Pablo Street, Los Angeles, CA 90033
In preclinical research we have dreamed about a 3D magnifying glass that would allow us to e.g. see various cell functions and structures in a dynamic 4D single scan, and map integrated detailed dynamics of e.g. contrast agents, tracers, pharmaceuticals, receptors and indicators of therapy response in tumors. To meet these and many other imaging needs we developed the user friendly fully integrated VECTor-6 imaging platform (WMIC innovation of the Year 2018) comprising:
A) down to 0.25 mm SPECT & 0.6 mm PET in vivo resolution, with positron-range free PET for otherwise difficult isotopes” like 124I, 76Br, 86Y, and 82Rb.
B) concurrent sub-mm multi-tracer PET & PET-SPECT
sub-second dynamic PET & SPECT
D) sub-mm resolution imaging of α & β-emitting pharmaceuticals,
E) ultra-high-performance low dose X-ray CT and F) Cherenkov, Fluorescence & Bioluminescence imaging including optical tomography.